Please login to the form below

Not currently logged in
Email:
Password:

MRC Technology

This page shows the latest MRC Technology news and features for those working in and with pharma, biotech and healthcare.

LifeArc takes $30m equity stake in Kymab, gains access to antibody tech

LifeArc takes $30m equity stake in Kymab, gains access to antibody tech

This unique opportunity with Kymab provides us with a new technology platform to rapidly generate the best antibodies across a range of therapeutic targets.”. ... This is thanks to LifeArc’s work (then known as MRC Technology) in humanising the mouse

Latest news

More from news
Approximately 2 fully matching, plus 11 partially matching documents found.

Latest appointments

  • MRC Technology appoints director of technology transfer MRC Technology appoints director of technology transfer

    Andrew Farquharson will join the firm from September 1. MRC Technology has named Andrew Farquharson as director of technology transfer, effective from September 1. ... Dr Dave Tapolczay, CEO at MRC Technology, added: “Andrew's extensive experience will

  • MRC Technology names finance director MRC Technology names finance director

    Andrew Mercieca took up the role on April 1. Independent life science medical research charity MRC Technology has named Andrew Mercieca as its finance director. ... Dave Tapolczay, CEO at MRC Technology, added: “Andrew has been a great asset to the

More from appointments
Approximately 2 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
COUCH Health

We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics